Electroencephalography in the Management of Neuroelectric Stimulation in Patients With Severe Traumatic Brain Injuries
Launched by RENJI HOSPITAL · Aug 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special test called electroencephalography (EEG) can help doctors understand and treat patients who have suffered severe traumatic brain injuries (TBIs). Researchers want to find out if EEG results change after these patients receive a treatment known as neuroelectric stimulation, and how EEG can be used to assess their condition over time.
To participate in this study, potential candidates must be at least 18 years old and have experienced a severe TBI, which is measured by a specific scoring system. They should be at least seven days post-injury and have a score between 3 and 8. However, individuals with certain health issues, like unstable vital signs or a history of serious mental disorders, may not be eligible. If you or someone you know meets these criteria, participating in the trial could provide valuable insights into how EEG can improve care for patients with severe brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 7 days after severe traumatic brain injuries (GCS score 3-8);
- • Over 18 years old, regardless of gender;
- • The patient's legal representative is informed and voluntarily signs the consent form.
- Exclusion Criteria:
- • Unstable vital signs;
- • History of mental disorders or neurodegenerative diseases;
- • Uncontrolled epilepsy;
- • Severe arrhythmias or patients with implanted cardiac pacemakers;
- • Various conditions that interfere with scalp EEG collection;
- • Pregnant women.
About Renji Hospital
Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Junfeng Feng, Ph.D.
Principal Investigator
RenJi Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported